An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing
about
Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic populationThe APOA5 Trp19 allele is associated with metabolic syndrome via its association with plasma triglyceridesEffects of apoA-V on HDL and VLDL metabolism in APOC3 transgenic miceAPOA5 gene variants, lipoprotein particle distribution, and progression of coronary heart disease: results from the LOCAT studyArchitectural roles of multiple chromatin insulators at the human apolipoprotein gene clusterECR Browser: a tool for visualizing and accessing data from comparisons of multiple vertebrate genomesRegulation of hepatic ApoC3 expression by PGC-1β mediates hypolipidemic effect of nicotinic acidSystematic discovery of regulatory motifs in human promoters and 3' UTRs by comparison of several mammalsMolecular processes that handle -- and mishandle -- dietary lipidsSix new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humansEndocytosis of apolipoprotein A-V by members of the low density lipoprotein receptor and the VPS10p domain receptor familiesGlycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicronsAssociation of SNP3 polymorphism in the apolipoprotein A-V gene with plasma triglyceride level in Tunisian type 2 diabetesMulti-species sequence comparison: the next frontier in genome annotationAPOAV (T-1131>C) variant has no effect on mother's height in a large population studyGenetic variants in Apolipoprotein AV alter triglyceride concentrations in pregnancyHuman-zebrafish non-coding conserved elements act in vivo to regulate transcriptionVariation in conserved non-coding sequences on chromosome 5q and susceptibility to asthma and atopy.Hypertriglyceridemia and Cardiovascular Diseases: RevisitedNeuroendorine and Epigentic Mechanisms Subserving Autonomic Imbalance and HPA Dysfunction in the Metabolic SyndromeApolipoprotein A-V gene therapy for disease prevention / treatment:a critical analysisNext-generation gene discovery for variants of large impact on lipid traitsApolipoprotein A5, a crucial determinant of plasma triglyceride levels, is highly responsive to peroxisome proliferator-activated receptor alpha activatorsThe human apolipoprotein AV gene is regulated by peroxisome proliferator-activated receptor-alpha and contains a novel farnesoid X-activated receptor response elementThe APOA5 locus is a strong determinant of plasma triglyceride concentrations across ethnic groups in SingaporeFenofibrate: a novel formulation (Triglide) in the treatment of lipid disorders: a reviewImpact of apolipoprotein A5 variants on statin treatment efficacyApolipoprotein A-V dependent modulation of plasma triacylglycerol: a puzzlementThe paradox of ApoA5 modulation of triglycerides: evidence from clinical and basic researchInfluence of apolipoprotein A-V on the metabolic fate of triacylglycerolA single nucleotide polymorphism in APOA5 determines triglyceride levels in Hong Kong and Guangzhou ChineseAPOA5 Ala315>Val, identified in patients with severe hypertriglyceridemia, is a common mutation with no major effects on plasma lipid levelsEffects of APOA5 -1131T>C (rs662799) on fasting plasma lipids and risk of metabolic syndrome: evidence from a case-control study in China and a meta-analysisIs apolipoprotein A5 a novel regulator of triglyceride-rich lipoproteins?APOA5 gene variation interacts with dietary fat intake to modulate obesity and circulating triglycerides in a Mediterranean populationPharmacogenetic association of the APOA1/C3/A4/A5 gene cluster and lipid responses to fenofibrate: the genetics of lipid-lowering drugs and diet network studyThe association between APOA5 haplotypes and plasma lipids is not modified by energy or fat intake: the Czech HAPIEE studyGenetic polymorphism of apolipoprotein A5 gene and susceptibility to type 2 diabetes mellitus: a meta-analysis of 15,137 subjectsMonogenic dyslipidemias: window on determinants of plasma lipoprotein metabolismGenetic Variants Associated with Gestational Hypertriglyceridemia and Pancreatitis
P2860
Q21133795-4EF72BB6-5D83-4B12-B482-8FCB0F7E2890Q21261422-F9ACC1BD-4B30-423C-883C-3DBD62A42D19Q24302828-3B35E403-81A9-417B-AED0-53335D87BE4BQ24305221-440247E2-776B-48F9-884D-5AC7E57EE54CQ24309356-15F5D6CE-D985-4BFD-BAB7-7E9CDBB7841CQ24562130-AA2B0030-E61D-4832-A6C9-8DB44CF3A6BCQ24594113-DBE683A7-F0B0-4255-B544-9F682D561C33Q24630840-A6CF0B3D-E931-453D-8C17-D6251380DCBDQ24642118-B187F0E9-7125-499D-8249-79B9D9637AAFQ24643492-4F93F9D0-B403-4073-B310-0F9A5D30C35BQ24651670-EF919D28-D23B-4CB0-9553-39FC5EFDC74FQ24677013-A762B3F6-04EC-48C5-8DBC-D4BF3F24E969Q24791712-F7FD1C2B-393D-4A94-BB99-128E5FDF69CFQ24793480-9D44ACFB-9A9D-4E80-AA7E-95B15AB791D6Q24794937-92D6F226-02E3-4373-B9F7-84AE4263348FQ24797224-F9DA02B4-C094-46B8-8443-56186DE150F8Q24816250-6459CE4C-A402-4861-9ED4-C048DB8464AFQ25257590-1D962266-D3F9-41FE-9C00-67D173CD5124Q26750954-0F091BE5-D4B0-4CF7-AE50-CB7F5D1E21D3Q26752744-685439A0-1175-4878-9A86-D6E9A0B0CF9AQ26775009-70AABA1A-E715-4BC4-9FD6-F3E6F2C81BF2Q28088415-07BB8622-97D3-4FC3-9017-AD3407FC6EE7Q28183207-74924234-2FAD-4BFB-B815-6AC3378E6DD8Q28199120-1A5C5B58-5D14-4742-B943-7012EF4513E5Q28204618-DF8CC8C3-344B-4250-B1BD-55A9A28C6BE7Q28220294-1B00AF5B-B530-4A01-A253-FFD3EE8F71A0Q28248690-7048F380-71B5-46F8-A76F-21BEB70EEE1AQ28256394-61F137AF-32F8-452E-84E9-F17B4792199CQ28275573-17C10745-4132-43D2-AB8C-367FEDBD804DQ28281468-BE8E500D-7CE3-49FC-8649-6C96AF3CC14DQ28286033-E9237B48-B1F8-4E9E-BA95-A7EB1AEEE535Q28286099-E4ED8F3E-63EA-4669-B25C-768CE42E6CD3Q28286797-5C1F9AFA-49FB-4A2D-B6D2-BD1D73EE3FA0Q28294769-AF8FC8AF-0589-4DAE-BFDC-BACD40C69677Q28302513-C6310DFD-4EBF-4B79-B679-CEEF7A57BFB6Q28302934-2FE7A82B-AC74-4C3D-A4D9-E64F6B2F4B48Q28306572-060CEB20-7CF2-4B6D-8C2B-3C4F951F9716Q28308177-283CFBE3-F105-499B-86A6-3A33F6759196Q28363810-8CC0D39B-5C50-4000-BC8D-96D0BE2EBB59Q28548394-7A057BA4-8C54-4838-8D09-BFD7E7C3FF8D
P2860
An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
An apolipoprotein influencing ...... aled by comparative sequencing
@ast
An apolipoprotein influencing ...... aled by comparative sequencing
@en
An apolipoprotein influencing ...... aled by comparative sequencing
@en-gb
An apolipoprotein influencing ...... aled by comparative sequencing
@nl
type
label
An apolipoprotein influencing ...... aled by comparative sequencing
@ast
An apolipoprotein influencing ...... aled by comparative sequencing
@en
An apolipoprotein influencing ...... aled by comparative sequencing
@en-gb
An apolipoprotein influencing ...... aled by comparative sequencing
@nl
prefLabel
An apolipoprotein influencing ...... aled by comparative sequencing
@ast
An apolipoprotein influencing ...... aled by comparative sequencing
@en
An apolipoprotein influencing ...... aled by comparative sequencing
@en-gb
An apolipoprotein influencing ...... aled by comparative sequencing
@nl
P2093
P921
P3181
P356
P1433
P1476
An apolipoprotein influencing ...... aled by comparative sequencing
@en
P2093
J A Hubacek
L A Pennacchio
R M Krauss
P304
P3181
P356
10.1126/SCIENCE.1064852
P407
P577
2001-10-05T00:00:00Z